#640583
Ba cheart go mbeadh na hamlínte chun sainchomhad iarratais ar thrialacha cliniciúla a mheasúnú fada go leor le gur féidir an comhad a mheasúnú, ach rochtain mhear ar chóireálacha nuálaíocha nua a áirithiú ag an am céanna, agus ba cheart go n-áiritheofaí gur áit tharraingteach é an tAontas i gcónaí chun trialacha cliniciúla a stiúradh.
The timelines for assessing an application dossier for clinical trials should be sufficient to assess the file while, at the same time, ensuring quick access to new, innovative treatments and ensuring that the Union remains an attractive place for conducting clinical trials.